Breaking News Instant updates and real-time market news.

ABT

Abbott

$76.23

-1.27 (-1.64%)

09:16
04/17/19
04/17
09:16
04/17/19
09:16

Abbott sees FY19 organic sales growth 6.5%-7.5%

Says exchange to have negative impact of 2.5% on FY results, with majority expected to occur in 1H. Sees FY gross margin "somewhat above" 59.5% of net sales. Sees MSD sales growth for established pharmaceuticals in Q2. Sees mid single digit growth for Nutrition for Q2. Sees HSD sales growth for Q2 in Medical Devices.

  • 17

    Apr

  • 26

    Apr

  • 30

    Apr

  • 06

    May

  • 08

    May

ABT Abbott
$76.23

-1.27 (-1.64%)

03/22/19
BMOC
03/22/19
NO CHANGE
Target $204
BMOC
Outperform
Edwards Lifesciences price target raised to $204 from $190 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on Edwards Lifesciences (EW) to $204 and kept her Outperform rating while removing the stock from her Top Picks list after its 25% year-to-date run-up. While there are some mid-year catalysts for the company such as the outcomes from the CMS NationalCoverage Decision proposal on March 27, clinical data from Pascal, and patent litigation with Abbott (ABT) regarding Pascal, the analyst contends that some consolidation in the stock price would not be surprising.
03/26/19
PIPR
03/26/19
NO CHANGE
Target $165
PIPR
Overweight
Piper discusses 16% selloff in DexCom over past three trading days
Piper Jaffray analyst JP McKim says he's fielded a lot of investor questions with shares of DexCom (DXCM) down 16% over the last three trading days. The crux of the selloff is Abbott's (ABT) Libre 2.0 and whether it gets interoperable continuous glucose monitoring and if so, what that does to volumes and price, McKim tells investors in a research note. The analyst sees little risk to DexCom's volumes for given the market inflection for continuous glucose monitoring, but adds that if Libre gets iCGM "payers maybe push a little harder on price." McKim admits that "headline risk is building around the approval" but keeps an Overweight rating on DexCom shares with a $165 price target. Libre 2.0 getting iCGM is not fully priced in the stock at this point, but some of that risk certainly is, says McKim.
04/03/19
JPMS
04/03/19
NO CHANGE
Target $175
JPMS
Overweight
JPMorgan remains 'very bullish' on DexCom despite Libre 2.0 uncertainty
The latest DexCom (DXCM) controversy is "whirling speculation" around Abbott's (ABT) Libre 2.0 launch, JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst keeps an Overweight rating on DexCom shares with a $175 price target but expects uncertainty over Libre 2.0 to remain an overhang until it receives U.S. approval. However, he remains "very bullish" on the shares and sees "significant upside" to 2019 estimates. DexComis the best positioned in diabetes longer-term, Marcus contends.
04/15/19
RBCM
04/15/19
NO CHANGE
Target $82
RBCM
Sector Perform
Abbott price target raised to $82 from $77 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Abbott to $82 ahead of its Q1 results, saying the "pattern of revenue growth" seen last year should continue this quarter as Core Laboratory, Electrophysiology, Structural Heart, and Diabetes Care product categories "lead the way." The analyst also expects Abbott's organic revenue growth in the Medical Devices segment to come at the high end of guidance, adding that while his new price target implies a multiple of 22.5-times vs. peer group's 21-times, he believes that the company's growth profile justifies the valuation premium. Henry recommends that investors buy the stock on "any weakness".

TODAY'S FREE FLY STORIES

OKE

Oneok

$69.13

-0.59 (-0.85%)

16:17
04/18/19
04/18
16:17
04/18/19
16:17
Hot Stocks
Oneok increases quarterly dividend 9% to 86.5c per share »

Oneok increased its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
04/18/19
04/18
16:17
04/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
04/18/19
04/18
16:16
04/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

$28.23

0.51 (1.84%)

16:16
04/18/19
04/18
16:16
04/18/19
16:16
Hot Stocks
Holly Energy Partners raises dividend to 67c per unit from 66.75c »

The distribution will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

HES

Hess Corp.

$65.87

-0.05 (-0.08%)

16:15
04/18/19
04/18
16:15
04/18/19
16:15
Hot Stocks
Hess Corp. announces 13th discovery offshore Guyana »

Hess Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 22

    May

  • 29

    May

16:15
04/18/19
04/18
16:15
04/18/19
16:15
General news
Breaking General news story  »

Week of 4/17 Fed Balance…

16:15
04/18/19
04/18
16:15
04/18/19
16:15
General news
Breaking General news story  »

Week of 4/8 Money Supply…

DTRM

Determine

$0.00

(0.00%)

16:13
04/18/19
04/18
16:13
04/18/19
16:13
Hot Stocks
Determine announces winding up, liquidation, and dissolution »

Determine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$10.67

-0.08 (-0.74%)

16:12
04/18/19
04/18
16:12
04/18/19
16:12
Hot Stocks
Prothena will explore potential business development opportunities for NEOD001 »

Prothena reports results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

FFIN

First Financial

$60.25

-0.32 (-0.53%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
First Financial reports Q1 EPS 56c, consensus 56c »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

INDB

Independent Bank

$84.23

-0.98 (-1.15%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
Independent Bank reports Q1 EPS $1.30, consensus $1.29 »

Reports Q1 NII $82.5M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 13

    May

  • 16

    May

EXPO

Exponent

$56.31

0.15 (0.27%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
Exponent reports Q1 EPS 42c, consensus 36c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

SRCE

1st Source

$46.04

-0.68 (-1.46%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
1st Source reports Q1 EPS 86c, consensus 85c »

According to Christopher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

AMNB

American National Bankshares

$35.04

-0.25 (-0.71%)

16:10
04/18/19
04/18
16:10
04/18/19
16:10
Earnings
Breaking Earnings news story on American National Bankshares »

American National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$60.71

0.56 (0.93%)

16:10
04/18/19
04/18
16:10
04/18/19
16:10
Hot Stocks
Lumentum sees revenue from datacom transceivers down $20M-$25M in Q4 »

Lumentum announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 28

    May

TRNO

Terreno Realty

$43.11

0.44 (1.03%)

16:09
04/18/19
04/18
16:09
04/18/19
16:09
Hot Stocks
Terreno Realty executes 192K sqm lease in Florida »

Terreno Realty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 07

    May

  • 08

    May

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

, AKRX

Akorn

$2.77

-0.16 (-5.46%)

16:09
04/18/19
04/18
16:09
04/18/19
16:09
Hot Stocks
Innovus announces FDA approval for Akorn's ANDA for FlutiCare »

Innovus Pharmaceuticals…

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

AKRX

Akorn

$2.77

-0.16 (-5.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 07

    May

ISRG

Intuitive Surgical

$530.12

5.37 (1.02%)

16:09
04/18/19
04/18
16:09
04/18/19
16:09
Earnings
Intuitive Surgical says worldwide da Vinci procedures grew 18% »

Intuitive Surgical said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

  • 03

    May

ISRG

Intuitive Surgical

$529.84

5.09 (0.97%)

16:07
04/18/19
04/18
16:07
04/18/19
16:07
Earnings
Intuitive Surgical reports Q1 EPS $2.61, consensus $2.70 »

Reports Q1 revenue $974M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

  • 03

    May

UIHC

United Insurance

$16.45

0.28 (1.73%)

16:06
04/18/19
04/18
16:06
04/18/19
16:06
Hot Stocks
United Insurance estimates Q1 catastrophe losses of roughly $18M pre-tax »

United Insurance Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ADAP

Adaptimmune

$4.08

-0.23 (-5.34%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
Adaptimmune announces presentation of allogeneic SPEAR T-cell program at ASGCT »

Adaptimmune announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$145.34

-0.56 (-0.38%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
D.E. Shaw reports 5.0% passive stake in Wayfair »

D.E. Shaw disclosed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

PBCT

People's United

$17.12

-0.215 (-1.24%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
People's United raises annual dividend to 71c per share »

The company's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 16

    May

NNBR

NN, Inc.

$9.71

0.03 (0.31%)

16:05
04/18/19
04/18
16:05
04/18/19
16:05
Hot Stocks
NN, Inc.closing Tennessee shared service center »

NN, Inc. will close its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

PBCT

People's United

$17.13

-0.2 (-1.15%)

16:04
04/18/19
04/18
16:04
04/18/19
16:04
Hot Stocks
People's United reports Q1 net interest margin 3.2% »

Reports Q1 efficiency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.